GS0051: Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Preparation for the relief of pain; Opium alkaloid preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations
PM0000: GLEN MARK GENERICS INC., USA
D10000: "GENERICS INC., USA"
Case File Event Statements
1/21/2022 - 3 years ago
60 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9Type:CAEX
7/19/2020 - 4 years ago
59 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILEDType:REM2
9/5/2017 - 7 years ago
58 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILEDType:NAS8
9/5/2017 - 7 years ago
57 - REGISTERED - SEC. 8 (6-YR) ACCEPTEDType:8.OK
8/23/2017 - 7 years ago
56 - CASE ASSIGNED TO POST REGISTRATION PARALEGALType:APRE
7/14/2017 - 7 years ago
55 - TEAS SECTION 8 RECEIVEDType:ES8R
7/19/2011 - 13 years ago
54 - REGISTERED-PRINCIPAL REGISTERType:R.PR
6/16/2011 - 13 years ago
53 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILEDType:SUNA
6/15/2011 - 13 years ago
52 - LAW OFFICE REGISTRATION REVIEW COMPLETEDType:REGV
6/10/2011 - 13 years ago
51 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTEDType:CNPR
6/10/2011 - 13 years ago
50 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
6/9/2011 - 13 years ago
49 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
6/7/2011 - 13 years ago
48 - USE AMENDMENT FILEDType:IUAF
6/9/2011 - 13 years ago
47 - EXTENSION 4 GRANTEDType:EX4G
4/21/2011 - 13 years ago
46 - EXTENSION 4 FILEDType:EXT4
6/7/2011 - 13 years ago
45 - TEAS STATEMENT OF USE RECEIVEDType:EISU
6/7/2011 - 13 years ago
44 - EXTENSION RECEIVED WITH TEAS PETITIONType:TPEX
6/7/2011 - 13 years ago
43 - PETITION TO REVIVE-GRANTEDType:PETG
6/7/2011 - 13 years ago
42 - TEAS PETITION TO REVIVE RECEIVEDType:PROA
5/23/2011 - 13 years ago
41 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDType:MAB6
5/23/2011 - 13 years ago
40 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
10/28/2010 - 14 years ago
39 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
10/27/2010 - 14 years ago
38 - EXTENSION 3 GRANTEDType:EX3G
10/21/2010 - 14 years ago
37 - EXTENSION 3 FILEDType:EXT3
10/26/2010 - 14 years ago
36 - EXTENSION RECEIVED WITH TEAS PETITIONType:TPEX
10/26/2010 - 14 years ago
35 - PETITION TO REVIVE-GRANTEDType:PETG
10/26/2010 - 14 years ago
34 - TEAS PETITION TO REVIVE RECEIVEDType:PROA
5/21/2010 - 14 years ago
33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
5/20/2010 - 14 years ago
32 - EXTENSION 2 GRANTEDType:EX2G
4/21/2010 - 14 years ago
31 - EXTENSION 2 FILEDType:EXT2
5/19/2010 - 14 years ago
30 - EXTENSION RECEIVED WITH TEAS PETITIONType:TPEX